New York State Common Retirement Fund Kaleido Biosciences, Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.05 - $1.7 $453 - $15,424	-9,073 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$1.3 - $2.7 $13 - $27	-10 Reduced 0.11%	9,073 $15,000
Q3 2021 Nov 02, 2021	BUY	$5.36 - $7.99 $423 - $631	79 Added 0.88%	9,083 $50,000
Q2 2021 Aug 02, 2021	BUY	$5.82 - $8.72 $605 - $906	104 Added 1.17%	9,004 $67,000
Q2 2019 Aug 09, 2019	BUY	$11.25 - $18.1 $100,125 - $161,090	8,900 New	8,900 $103,000

2.3K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.